Canertinib
|
卡奈替尼
|
267243-28-7
|
AEE788 (NVP-AEE788)
|
6-[4-[(4-乙基-1-哌嗪)甲基]苯基]-N-[(1R)-1-苯基乙基]-7H-吡咯并[2,3-D]嘧啶-4-胺
|
497839-62-0
|
Pyrotinib dimaleate
|
馬來酸吡咯替尼
|
1397922-61-0
|
RTC-5
|
RTC-5
|
1423077-49-9
|
EGFR-IN-7
|
5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺
|
2267329-76-8
|
Thalidomide-PEG2-C2-NH2 TFA
|
Thalidomide-NH-PEG2-C2-NH2 (TFA)
|
2097509-36-7
|
BI-4020
|
RESATORVID
|
2664214-60-0
|
UniPR129
|
化合物 T26310
|
1639159-47-9
|
Gefitinib hydrochloride
|
4-(3-氯-4-氟苯基氨基)-7-甲氧基-6-[3-(4-嗎啉基)丙氧基]喹唑啉鹽酸鹽
|
184475-55-6
|
Varlitinib (ARRY334543)
|
泛EGFR小分子抑制劑(VARLITINIB)
|
845272-21-1
|
JI-101
|
JI-101
|
900573-88-8
|
AP26113
|
AP26113
|
1197958-12-5
|
Mavelertinib
|
PF-06747775
|
1776112-90-3
|
(S,R,S)-AHPC-PEG4-NH2 hydrochloride
|
2064292-52-8
|
2064292-52-8
|
Pomalidomide-PEG1-C2-COOH
|
POMALIDOMIDE-PEG 1-CO 2 H
|
2139348-60-8
|
(S,R,S)-AHPC-PEG3-NH2
|
E3 ligase Ligand-Linker Conjugates 5 Free Base
|
2010159-56-3
|
Almonertinib
|
阿美替尼
|
1899921-05-1
|
Pomalidomide-amino-PEG3-NH2 hydrochloride
|
POMALIDOMIDE-PEG3-NH2鹽酸鹽
|
2380273-75-4
|
NVP-BHG712 isomer
|
NVP-BHG712 isomer
|
2245892-85-5
|
Pomalidomide-PEG3-C2-NH2 TFA
|
沙利度胺-NH-PEG3-NH2 TFA
|
2414913-97-4
|
NSC689857
|
化合物 T25889
|
241127-79-7
|
Trastuzumab deruxtecan
|
Trastuzumab Deruxtecan
|
1826843-81-5
|
Pomalidomide-PEG4-C2-NH2 hydrochloride
|
泊馬度胺4'-PEG4-胺
|
2357105-92-9
|
Tyrphostin AG30
|
酪氨酸磷酸化抑制劑 AG 30
|
122520-79-0
|
WZ8040
|
WZ8040
|
1214265-57-2
|
Lapatinib-d4
|
Lapatinib-d4
|
1184263-99-7
|
Icotinib Hydrochloride
|
凱美納
|
1204313-51-8
|
AST-1306 TsOH
|
艾力替尼
|
1050500-29-2
|
Theliatinib
|
席栗替尼
|
1353644-70-8
|
Thalidomide-O-amido-PEG3-C2-NH2 TFA
|
1957236-21-3
|
1957236-21-3
|
AG-18
|
酪氨酸磷酸化抑制劑23
|
118409-57-7
|
VH032-PEG5-C6-Cl
|
1799506-06-1
|
1799506-06-1
|
Alflutinib mesylate
|
AST2818甲磺酸鹽
|
2130958-55-1
|
JND3229
|
JND3229
|
2260886-64-2
|
123C4
|
化合物123C4
|
2034159-30-1
|
MRT00033659
|
MRT00033659
|
1401731-54-1
|
Golgicide A-2
|
GOLGICIDE A-2
|
1394285-50-7
|
Pomalidomide 4'-PEG2-azide
|
4-((2-(2-(2-azidoethoxy)ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
|
2271036-45-2
|
Lapatinib ditosylate monohydrate
|
二甲苯磺酸拉帕替尼
|
388082-78-8
|
Nazartinib
|
EGF816
|
1508250-71-2
|
Gefitinib-based PROTAC 3
|
Gefitinib-based PROTAC 3
|
2230821-27-7
|
Antiviral agent 24
|
N6-(3-Trifluoromethylbenzyl)adenosine
|
23661-03-2
|
ML401
|
ML401
|
1597489-14-9
|
(S,R,S)-AHPC-phenol-C4-NH2 dihydrochloride
|
(S,R,S)-AHPC-PHENOL-C4-NH2 (DIHYDROCHLORIDE)
|
2376990-26-8
|
(S,R,S)-AHPC-PEG5-COOH
|
E3 Ligase Ligand-Linker Conjugates 58
|
2172820-14-1
|
Rezivertinib
|
REZIVERTINIB
|
1835667-12-3
|
PKI-166
|
PKI 166
|
187724-61-4
|
BMS-690514
|
(3R,4R)-4-氨基-1-[[4-[(3-甲氧基苯基)氨基]吡咯并[2,1-F][1,2,4]三嗪-5-基]甲基]哌啶-3-醇
|
859853-30-8
|
AP-III-a4
|
AP-III-A4
|
1177827-73-4
|
MX69
|
MX69
|
1005264-47-0
|
EAI001
|
2-(1-氧代異吲哚啉-2-基)-2-苯基-N-(噻唑-2-基)乙酰胺
|
892772-75-7
|
Pomalidomide-PEG2-COOH
|
POMALIDOMIDE-PEG2-CO 2 H
|
2140807-17-4
|
OSI-420 free base
|
2-[[4-[(3-乙炔基苯基)氨基]-7-(2-甲氧基乙氧基)-6-喹唑啉基]氧基]乙醇
|
183321-86-0
|
AZ7550 Mesylate
|
AZ7550 Mesylate
|
2319837-99-3
|
AG-1478
|
AG1478
|
153436-53-4
|
Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 TFA
|
THALIDOMIDE-O-AMIDO-PEG1-(C1-?PEG)2-C2-NH2
|
2435572-49-7
|
Pirodavir
|
吡羅達(dá)韋
|
124436-59-5
|
CP-724714
|
2-甲氧基-N-[3-[4-[[3-甲基-4-[(6-甲基-3-吡啶基)氧基]苯基]氨基]-6-喹唑啉基]-2-丙烯-1-基]乙酰胺
|
537705-08-1
|
AZD3759
|
AZD3759
|
1626387-80-1
|
Pomalidomide-PEG4-C-COOH
|
E3 Ligase Ligand-Linker Conjugates 1
|
2097938-44-6
|
Thalidomide-O-amido-C3-COOH
|
E3 ligase Ligand-Linker Conjugates 15
|
2308035-51-8
|
Thalidomide-O-amido-C8-NH2 TFA
|
1950635-16-1
|
1950635-16-1
|
TAS0728
|
TAS0728
|
2088323-16-2
|
Thalidomide-O-C6-COOH
|
Heptanoic acid, 7-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-
|
2169266-69-5
|
Thalidomide-Piperazine-PEG1-COOH
|
|
2731007-11-5
|
Teslexivir hydrochloride
|
BTA074 HYDROCHLORIDE ; AP 611074 HYDROCHLORIDE|||BTA074 HYDROCHLORIDE|||AP 611074 HYDROCHLORIDE
|
1075281-70-7
|
Rupintrivir
|
(2E,4S)-4-[(2R,5S)-2-(4-氟芐基)-6-甲基-5-(5-甲基異惡唑-3-基甲酰氨基)-4-氧代庚酰氨基]-5-[[(3S)-2-氧代-3-吡咯烷基]-2-戊烯酸乙酯
|
223537-30-2
|
ARRY-380 analog
|
ARRY-380
|
937265-83-3
|
GSK682753A
|
1334294-76-6
|
1334294-76-6
|
(S,R,S)-AHPC-(C3-PEG)2-C6-Cl
|
1835705-61-7
|
1835705-61-7
|
Thalidomide-O-amido-C4-NH2 TFA
|
1799711-25-3
|
1799711-25-3
|
Zipalertinib
|
齊帕勒替尼
|
1661854-97-2
|
Thalidomide-piperazine-Boc
|
1-Piperazinecarboxylic acid, 4-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]-, 1,1-dimethylethyl ester
|
2222114-64-7
|
Hydrocotarnine
|
hydrocotarnine
|
550-10-7
|
PD153035 hydrochloride
|
4-[(3-溴苯基)氨基]-6,7-二甲氧基喹啉
|
153436-54-5
|
Mutant EGFR inhibitor
|
N-[5-[[5-氯-4-(1H-吲哚-3-基)-2-嘧啶基]氨基]-2-[[2-(二甲基氨基)乙基]甲基氨基]-4-甲氧基苯基]-2-丙烯酰胺
|
1421373-62-7
|
(E/Z)-AG490
|
酪氨酸磷酸化抑制劑AG490
|
134036-52-5
|
Thalidomide-NH-C6-NH2 TFA
|
Thalidomide-NH-C6-NH2 TFA
|
2093386-51-5
|
EGFR-IN-11
|
EGFR-IN-11
|
2463200-44-2
|
Pomalidomide-amino-PEG5-NH2 hydrochloride
|
泊馬度胺-五聚乙二醇-氨基鹽酸鹽
|
2421217-05-0
|
AST-1306
|
AST-1306
|
897383-62-9
|
AZD-9291 (Mesylate)
|
AZD9291(甲磺酸鹽)
|
1421373-66-1
|
NIBR189
|
NIBR189
|
1599432-08-2
|
EAI045
|
EAI-045
|
1942114-09-1
|
PD168393
|
PD168393
|
194423-15-9
|
Lazertinib
|
YH-25448
|
1903008-80-9
|
Simotinib
|
Simotinib
|
944258-89-3
|
Thalidomide-O-amido-C6-NH2 TFA
|
1950635-14-9
|
1950635-14-9
|
Thalidomide-NH-PEG3-propionic acid
|
Pomalidomide-PEG3-CO2H
|
2138440-82-9
|
Compound 56
|
N-(3-溴苯基)-6,7-二乙氧基-4-喹唑啉胺
|
171745-13-4
|
Pleconaril
|
普可那利
|
153168-05-9
|
Almonertinib mesylate
|
阿美替尼甲磺酸鹽
|
2134096-06-1
|
Thalidomide-O-amido-C3-PEG3-C1-NH2
|
沙利度胺-O-酰胺-C3-三聚乙二醇-C1-氨基
|
1799711-29-7
|
ONO-AE3-208
|
4-氰基-2-[[2-(4-氟-1-萘基)-1-氧代丙基]氨基]苯基丁酸
|
402473-54-5
|
HLM006474
|
CS-1224
|
353519-63-8
|
(S,R,S)-AHPC-PEG2-N3
|
2010159-45-0
|
2010159-45-0
|
RG 13022
|
RG-13022
|
136831-48-6
|
Thalidomide 4'-ether-alkylC2-amine hydrochloride
|
Thalidomide-linker 6
|
2341840-99-9
|
Pomalidomide-PEG1-C2-N3
|
E3 ligase Ligand-Linker Conjugates 50
|
2271036-44-1
|
Thalidomide-NH-C4-NH-Boc
|
泊馬度胺-NH-C4-氨基叔丁酯
|
2093388-52-2
|